Pelcitoclax (APG-1252)

Pelcitoclax · Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pelcitoclax (APG-1252), covering 2025-04-17 to 2025-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors [Phase 1]